コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ascular endothelial growth factor) and PDGF (platelet derived growth factor).
2 ristics when exposed to cholesterol or PDGF (platelet-derived growth factor).
3 ascular endothelial growth factor (VEGF) and platelet-derived growth factor.
4 wing stimulation with interleukin-1alpha and platelet-derived growth factor.
5 CCN2 (connective tissue growth factor), and platelet-derived growth factor.
6 and PKM2 oxidation in cells stimulated with platelet-derived growth factor.
8 r receptor alpha (PDGFRalpha) and its ligand platelet-derived growth factor A (PDGF-A) are co-express
13 s (angiopoietin 2; hepatocyte growth factor; platelet-derived growth factor AA and BB; placental grow
16 broblasts exhibit impaired responsiveness to platelet-derived growth factor-AA and sonic hedgehog, tw
17 rotrophic factor, fibroblast growth factors, platelet-derived growth factor-AA, vascular endothelial
18 [TGF-beta1], epidermal growth factor [EGF], platelet-derived growth factor AB [PDGF-AB], and albumin
19 tor, vascular endothelial growth factor, and platelet-derived growth factor AB) before and after comp
21 e Boyden chamber and show that a gradient of platelet-derived growth factor-AB (PDGF-AB) expedites mi
22 sient treatment with AZA in combination with platelet-derived growth factor-AB converts primary somat
24 1, and transiently suppressed myofibroblast platelet-derived growth factor alpha differentiation mar
25 a similar level of TNF-alpha, TGF-beta1, and platelet-derived growth factor alpha genes, and a high l
26 cts with HEUS and in untreated subjects with platelet-derived growth factor alpha-negative HES (n = 2
28 proteins (four antibodies and the chemokine platelet-derived growth factor) and two monovalent prote
30 flammatory cytokines, invade Matrigel toward platelet-derived growth factor, and resist hypoxia-induc
31 th factors, such as epidermal growth factor, platelet-derived growth factor, and Wnt; and hormones, s
32 o mediate the secretion of Pvf, a ligand for platelet-derived growth factor- and vascular endothelial
33 ice, including interleukin-1beta (IL-1beta), platelet-derived growth factor, angiopoietin 2, insulin-
36 morphogen sonic hedgehog (Shh) is driven by platelet-derived growth factor B (PDGF-BB) in vascular s
37 , myogenesis regulating glycosidase (MYORG), platelet-derived growth factor B (PDGFB) and platelet-de
39 ar endothelial growth factor A (VEGF-A), and platelet-derived growth factor B chain (PDGF-BB), to sti
40 expression of vascular endothelial cadherin, platelet-derived growth factor B, S1P(1), and CCN1 (mole
41 nd AKT and compared them to oligodendroglial platelet-derived growth factor B-induced tumors in Ctv-a
42 r receptor in mice bearing RCAS/tv-a-induced platelet-derived growth factor B-overexpressing glioblas
44 h, we demonstrate that two of these pathways-platelet-derived growth factor BB (PDGF BB) and neural p
46 ed a fibronectin peptide (P12) that can bind platelet-derived growth factor BB (PDGF-BB) and promote
48 ulated by ECFC-derived paracrine factors via platelet-derived growth factor BB (PDGF-BB)/platelet-der
49 study participants, the angiogenic cytokine platelet-derived growth factor BB glycoprotein correlate
51 sely, PCSK6 overexpression increased PDGFBB (platelet-derived growth factor BB)-induced cell prolifer
52 henotype was hyperproliferative to serum and platelet-derived growth factor BB, and unresponsive to t
53 lated with IL (interleukin)-1alpha and PDGF (platelet-derived growth factor)-BB with SMILR knockdown
54 present study was to evaluate the levels of platelet derived growth factor-BB (PDGF-BB) in gingival
55 ession of the spliced XBP1 or treatment with platelet derived growth factor-BB up-regulated miR-150 e
56 tors such as tumor necrosis factor-alpha and platelet derived growth factor-BB were also found to inc
57 sed approach is shown here to work with both platelet-derived growth factor-BB (PDGF-BB) and vascular
58 ), which when tethered to a surface acted as platelet-derived growth factor-BB (PDGF-BB) enhancers to
60 lar endothelial growth factor-A (VEGF-A) and platelet-derived growth factor-BB (PDGF-BB) that were en
61 sforming growth factor-alpha (TGF-alpha) and platelet-derived growth factor-BB (PDGF-BB) were reduced
62 helial growth factor-A (VEGF-A) isoforms and platelet-derived growth factor-BB (PDGF-BB), mainly thro
63 the receptor tyrosine kinase (RTK) agonist, platelet-derived growth factor-BB (PDGF-BB)-induced p21C
64 rom the culture of fat with ROS or PGZ on i) platelet-derived growth factor-BB (PDGF-BB)-stimulated p
67 atrix derivative (EMD) and recombinant human platelet-derived growth factor-BB (rhPDGF-BB) with beta-
68 e graft (CTG) (control) or recombinant human platelet-derived growth factor-BB + beta-tricalcium phos
69 tor-2, transforming growth factor-beta1, and platelet-derived growth factor-BB at 2 weeks compared wi
71 amel matrix derivative and recombinant human platelet-derived growth factor-BB plus beta-tricalcium p
72 s 200 ng of bone morphogenetic protein-2 and platelet-derived growth factor-BB that were eluted over
73 growth factor, interleukin 6, angiopoietin, platelet-derived growth factor-BB, placental growth fact
74 matory cytokines interferon gamma, IL-1, and platelet-derived growth factor-BB, which are not produce
76 ombination of lentiviral vectors, expressing platelet-derived growth factor beta (PDGF-B), constituti
78 sessed relationships between tau and soluble platelet-derived growth factor beta (sPDGFRbeta), a CSF
79 nds to the transmembrane domain (TMD) of the platelet-derived growth factor beta receptor (PDGFbetaR)
80 ing smooth muscle alpha-actin (alphaSMA) and platelet-derived growth factor beta receptor (PDGFbetaR)
81 le amino acid substitutions can activate the platelet-derived growth factor beta receptor or the eryt
82 d cells by forming a stable complex with the platelet-derived growth factor beta receptor transmembra
84 sions of fibrosis-related proteins including platelet-derived growth factor beta, fibronectin and col
85 nteract with the transmembrane domain of the platelet-derived growth factor beta-receptor and specifi
88 despite constituting a small fraction of the platelet-derived growth factor-beta (PDGFRbeta)(+) cell
89 nsforming growth factor-beta [TGF-beta], and platelet-derived growth factor-beta [PDGF-beta]) and blo
90 factor-D level, resulting in suppression of platelet-derived growth factor-beta activation and inhib
92 in, tissue inhibitor of metalloproteinase 1, platelet-derived growth factor c, transforming growth fa
95 layed by transforming growth factor-beta and platelet-derived growth factor D in driving the recruitm
96 phages, T cells, and platelets and increased platelet-derived growth factor D, Pdgfrb, Itga2, and mat
98 ortantly, itraconazole significantly reduced platelet-derived growth factor-D level, resulting in sup
99 ein oxidation within cells, and suggest that platelet-derived growth factor-dependent "redoxosomes,"
100 es insight into the vascular architecture of platelet-derived growth factor-driven glioblastoma.
103 cell neuroprotection, with factors from the platelet-derived growth factor family being the most pot
104 f activated T cells, epidermal growth factor/platelet-derived growth factor family members, Wnt/beta-
106 ulture self-assembled into microvessels, and platelet-derived growth factor had chemotactic effect on
107 on into brains of mice engineered to express platelet-derived growth factor in the central nervous sy
108 idence of and accelerated the development of platelet-derived growth factor -induced glioma in mice.
109 genetic deletion mutant in a mouse model of platelet-derived growth factor-induced malignant oligode
111 factor, vascular endothelial growth factor, platelet-derived growth factor, interleukin (IL)-8, IL-1
118 to delineate the transcriptional response to platelet-derived growth factor (PDGF) and fibroblast gro
119 rum response factor (SRF) is induced by both platelet-derived growth factor (PDGF) and fibroblast gro
123 e involved in the lipopolysaccharide-induced platelet-derived growth factor (PDGF) and Wnt signaling
124 10030 (Fovista; Ophthotech, New York, NY), a platelet-derived growth factor (PDGF) antagonist, admini
126 agonist [WAY-200070 (WAY)] with TNF-alpha or platelet-derived growth factor (PDGF) followed by evalua
127 d apoptotic priming, we examined the role of platelet-derived growth factor (PDGF) in CAF priming for
129 rowth factors, the most representative being platelet-derived growth factor (PDGF) isoforms (PDGF-AA,
130 ied KCE method to an experimental model of a platelet-derived growth factor (PDGF) protein and its DN
135 ascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptors, has sin
136 roblast chemotaxis directed by a gradient of platelet-derived growth factor (PDGF) requires signaling
137 -of-function alterations leading to enhanced platelet-derived growth factor (PDGF) signaling are comm
142 optical biosensing modulation by insulin and platelet-derived growth factor (PDGF) using the Aptamer-
143 ng a small interfering RNA (siRNA) targeting platelet-derived growth factor (PDGF) was used to allevi
145 clotted wound by a concentration gradient of platelet-derived growth factor (PDGF), together with oth
146 s transforming growth factor-beta (TGFbeta), platelet-derived growth factor (PDGF), WNT and hedgehog
150 EDE levels of VCAM-1, von Willebrand factor, platelet-derived growth factor (PDGF)-BB, angiopoietin-1
152 angiogenic factors, friend of Gata 2 (FOG2), platelet-derived growth factor (PDGF)-beta, and phosphat
154 e discovery of a novel ligand for PDGFRbeta, platelet-derived growth factor (PDGF)-DD, opened the pos
156 d quiescent mesenchymal cell activation in a platelet-derived growth factor (PDGF)-dependent manner.
158 ted knockdown of TRIM28 and TRIM27 inhibited platelet-derived growth factor (PDGF)-induced migration
159 ells (HASMCs); effect of Sema3E on basal and platelet-derived growth factor (PDGF)-induced proliferat
161 or small interfering RNA knockdown decreased platelet-derived growth factor (PDGF)-mediated migration
164 EC was uniformly inhibited by combined VEGF/platelet-derived growth factor (PDGF)/FGF receptor inhib
165 ular endothelial growth factor (VEGF) and 2) platelet-derived growth factor (PDGF-BB) in gingival cre
166 rCS3 binds the nerve growth factor (NGF) and platelet-derived growth factor (PDGF-BB), but the functi
168 1 overexpression increases the expression of platelet-derived growth factor (PDGFB) in human pulmonar
169 sforming growth factor beta 1 (TGFbeta1) and platelet-derived growth factor (PDGFbetabeta) stimulatio
171 cedures, including enamel matrix derivative, platelet-derived growth factor, platelet concentrates, a
172 factor], sCD40L [soluble CD40 ligand], PDGF [platelet-derived growth factor], RANTES [regulated on ac
176 ent of known imatinib targets including Abl, platelet derived growth factor receptor beta (PDGFRbeta)
177 razin-2(1H)-ones toward potent and effective platelet-derived growth factor receptor (PDGF-R) beta-in
178 ng fibroblast growth factor receptor (FGFR), platelet-derived growth factor receptor (PDGFR) and inte
180 st growth factor receptor (FGFR) family, the platelet-derived growth factor receptor (PDGFR) family,
182 YR mice had significantly reduced amounts of platelet-derived growth factor receptor (PDGFR), which i
184 platelet-derived growth factor BB (PDGF-BB)/platelet-derived growth factor receptor (PDGFR)-beta sig
185 isib also inhibited ALL proliferation in ABL/platelet-derived growth factor receptor (PDGFR)-mutant m
186 Anterograde transport mutants display low platelet-derived growth factor receptor (PDGFR)alpha lev
187 2), their coreceptor neuropilin1 (NRP1), and platelet-derived growth factor receptor (PDGFRalpha and
188 luded expected PI3K interactors, such as the platelet-derived growth factor receptor A (PDGFRA), as w
190 GG), often in association with TP53 loss and platelet-derived growth factor receptor alpha (PDGFRA) a
191 Nkx2.2 can directly bind to the promoter of platelet-derived growth factor receptor alpha (Pdgfra) a
192 rized by an oncogenic mutation in the KIT or platelet-derived growth factor receptor alpha (PDGFRA) g
194 ncogene, receptor tyrosine kinase (KIT), and platelet-derived growth factor receptor alpha (PDGFRA) i
195 -oncogene receptor tyrosine kinase (KIT) and platelet-derived growth factor receptor alpha (PDGFRA) m
196 a CRISPR/Cas9 strategy identified guinea pig platelet-derived growth factor receptor alpha (PDGFRA) t
197 errations in FLT3, tyrosine kinase 2 (TYK2), platelet-derived growth factor receptor alpha (PDGFRA),
198 l cells of Cajal (ICC), and cells expressing platelet-derived growth factor receptor alpha (PDGFRalph
200 ellular origin of new myelin by fate mapping platelet-derived growth factor receptor alpha (PDGFRalph
201 a poor prognosis and exhibit an increase in platelet-derived growth factor receptor alpha (PDGFRalph
203 that TAg expression reduces the abundance of platelet-derived growth factor receptor alpha (PDGFRalph
205 l cells of Cajal (ICC), and cells expressing platelet-derived growth factor receptor alpha (PDGFRalph
207 tion of H3.3 K27M cooperated with activating platelet-derived growth factor receptor alpha (PDGFRalph
208 f cone-driven photoresponses, were bred with platelet-derived growth factor receptor alpha (Pdgfralph
212 many different signaling pathways, including platelet-derived growth factor receptor alpha (PDGFRalph
213 ssed in primitive stromal cells that express platelet-derived growth factor receptor alpha and Sca-1
214 SMCs), interstitial cells of Cajal (ICC) and platelet-derived growth factor receptor alpha positive (
215 more, oncogenic RAB35 is sufficient to drive platelet-derived growth factor receptor alpha to LAMP2-p
217 led alpha1 adrenoceptors (ARs) expression in platelet-derived growth factor receptor alpha(+) cells (
218 Populations of enteric neurons, ICC, and platelet-derived growth factor receptor alpha(+) cells w
219 ating with an increase in Il-6 expression in platelet-derived growth factor receptor alpha(+) mesench
220 differentiated alpha-smooth muscle actin(+)/platelet-derived growth factor receptor alpha(+)/CD44(+)
221 roblast growth factor receptors 1 through 4, platelet-derived growth factor receptor alpha, RET, and
222 atrix by increasing nonmuscle myosin II- and platelet-derived growth factor receptor alpha-mediated c
223 ntramuscular interstitial cells of Cajal and platelet-derived growth factor receptor alpha-positive c
225 press the mesenchymal stem cell (MSC) marker platelet-derived growth factor receptor alpha; hence, we
226 N, resulting in increased phosphorylation of platelet-derived growth factor receptor and activation o
228 factor receptor, heat shock protein 90, and platelet-derived growth factor receptor as well as mutua
229 ling and functional screening identified the platelet-derived growth factor receptor b (PDGFRb) as bo
230 ranscriptional response to Mucorales reveals platelet-derived growth factor receptor B (PDGFRB) signa
231 n profiling, which revealed up-regulation of platelet-derived growth factor receptor beta (Pdgfrb) an
232 platelet-derived growth factor B (PDGFB) and platelet-derived growth factor receptor beta (PDGFRB), a
235 reased the catalytic loop phosphorylation of platelet-derived growth factor receptor beta (PDGFRbeta)
236 protein Sestrin 2 (Sesn2) as a suppressor of platelet-derived growth factor receptor beta (Pdgfrbeta)
237 MEFs show slower kinetics of ligand-induced platelet-derived growth factor receptor beta (PDGFRbeta)
238 Gint4.T aptamer specifically recognizes platelet-derived growth factor receptor beta and can cro
239 mooth muscle cells (ISMC) with expression of platelet-derived growth factor receptor beta and progres
240 [GRCh37/hg19]; c.1685A>G) change within the platelet-derived growth factor receptor beta gene (PDGFR
241 in 2 (IGFBP-2), nerve growth factor (b-NGF), platelet-derived growth factor receptor beta polypeptide
242 erved in a laser-induced model of CNV that a platelet-derived growth factor receptor beta positive (P
244 gnificantly more NIK(+) ECs and perivascular platelet-derived growth factor receptor beta(+) preFDCs,
245 g., expression of alpha smooth muscle actin, platelet-derived growth factor receptor beta, desmin, vi
248 structure provides a first glimpse into how platelet-derived growth factor receptor ECD, upon ligand
249 vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibitor PTK787
250 he vascular endothelial growth factor (VEGF)/platelet-derived growth factor receptor inhibitor suniti
251 cular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitor, demon
252 ntibody or with small molecule inhibitors of platelet-derived growth factor receptor kinase or downst
255 t epicardial-derived cells expressing PDGFR (platelet-derived growth factor receptor)-alpha were isol
256 tivation by a receptor activation loop (from platelet-derived growth factor receptor, a receptor tyro
257 lial cells and interstitial cells expressing platelet-derived growth factor receptor, alpha polypepti
258 ced RNA of epidermal growth factor receptor, platelet-derived growth factor receptor, and c-Met.
259 ing Smad3, epidermal growth factor receptor, platelet-derived growth factor receptor, signal transduc
260 xpressing cells, nestin-expressing cells and platelet-derived growth factor receptor-alpha (PDGFR-alp
261 progenitors expressing a mesodermal marker, platelet-derived growth factor receptor-alpha (PDGFRA),
262 ell lines revealed co-activation of HER2 and platelet-derived growth factor receptor-alpha (PDGFRalph
263 opulation (SP) phenotype, PECAM-1 (CD31) and platelet-derived growth factor receptor-alpha (PDGFRalph
264 could be identified with antibodies against platelet-derived growth factor receptor-alpha (PDGFRalph
266 and flow sorted to isolate cells expressing platelet-derived growth factor receptor-alpha and exclud
267 ssion pattern, manifest in downregulation of platelet-derived growth factor receptor-alpha and recipr
268 rogenesis from precursor cells by inhibiting platelet-derived growth factor receptor-alpha cell endoc
269 to stabilize detrusor excitability involving platelet-derived growth factor receptor-alpha positive (
271 ild-type or constitutively activated PDGFRA (platelet-derived growth factor receptor-alpha) under con
272 cells coexpressing vimentin and PDGFRalpha (platelet-derived growth factor receptor-alpha), but gene
273 tyrosine kinases (RTKs) such as PDGFRalpha (platelet-derived growth factor receptor-alpha), which sh
275 alpha signaling was conditionally blocked in platelet-derived growth factor receptor-alpha-positive a
276 y, 2) connective tissue progenitor cells, 3) platelet-derived growth factor receptor-alpha-positive c
278 nd dendritic spine formation through Rabex-5/platelet-derived growth factor receptor-beta (PDGFRbeta)
280 asculature followed by release of individual platelet-derived growth factor receptor-beta mural peric
281 iated capillary mural cell pericyte, soluble platelet-derived growth factor receptor-beta(8,18), and
282 a significant decrease in the expression of platelet-derived growth factor receptor-beta, a tyrosine
283 agent targeting VEGF receptors 1, 2, and 3, platelet-derived growth factor receptor-like protein (PD
286 structure of PDGFRbeta [a full-length human platelet-derived growth factor receptor], in complex wit
287 ne kinase activity of ABL1/BCR-ABL1 and KIT, platelet-derived growth factor receptors (PDGFRs), and t
290 of neuroprotective proteins and suggest that platelet-derived growth factor secretion in particular m
294 y model, with positive correlation to PDGFB (platelet-derived growth factor subunit B) and MMP (matri
295 ophages, which then provide signals (such as platelet-derived growth factor) that drive beta-cell hyp
296 fically, we show how this transducer enables platelet-derived growth factor to trigger (in vitro) the
297 is a milieu of bioactive factors, including platelet derived growth factor, transforming growth fact
298 the hepatic stellate cell (HSC) activators, platelet-derived growth factor, transforming growth fact
299 SMILR was also altered by interleukin-1alpha/platelet-derived growth factor treatment, and HAS2 expre
300 ine kinase ligands (epidermal growth factor, platelet-derived growth factor, vascular endothelial gro